Surgilight, ex-chairman, sued by SEC (US Securities and Exchange Commission) over stock manipulation
This article was originally published in Clinica
Executive Summary
The US Securities and Exchange Commission (SEC) is suing laser eye surgery company Surgilight, together with its former chairman and his wife, accusing them of a stock manipulation scheme, allowing them to reap $1.7 million in illicit proceeds.